Suchergebnisse - "Vermeire, S"

PubPharm (66)

1

Mesenteric SParIng versus extensive mesentereCtomY in primary ileocolic resection for ileocaecal Crohn's disease (SPICY) : study protocol for randomized controlled trial

enthalten in: BJS open | 2022

von van der Does de Willebois, E. | SPICY study group | Bemelman, W. | +16

CommentIn: BJS Open. 2022 May 2;6(3):. - PMID 35652587

2

Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease

enthalten in: Gastroenterology | 2018

von Weersma, R. | Xavier, R. | IBD Multi Omics Consortium | +35

3

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis : a Real-World Belgian Cohort Study

enthalten in: Inflammatory bowel diseases | 2018

von Van de Vondel, S. | Baert, F. | Reenaers, C. | +40

4

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results : an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Olivera, P. | Sandborn, W. | Panés, J. | +5

CommentIn: Aliment Pharmacol Ther. 2018 Apr;47(7):1032-1033. - PMID 29512917

5

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Vande Casteele, N. | Feagan, B. | Vermeire, S. | +4

6

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Dreesen, E. | Van Stappen, T. | Ballet, V. | +8

CommentIn: Aliment Pharmacol Ther. 2018 Mar;47(6):845-846. - PMID 29446128

7

Therapeutic innovations in inflammatory bowel diseases

enthalten in: Clinical pharmacology and therapeutics | 2016

von Vanhove, W. | Nys, K. | Vermeire, S.

8

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Coimbra, A. | Rimola, J. | O'Byrne, S. | +18

CommentIn: Aliment Pharmacol Ther. 2016 Mar;43(5):643-4. - PMID 26843335

9

Randomised clinical trial : vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2015

von Feagan, B. | Sandborn, W. | D'Haens, G. | +10

CommentIn: Aliment Pharmacol Ther. 2016 Aug;44(3):307-8. - PMID 27375100

10

Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease

enthalten in: Alimentary pharmacology & therapeutics | 2015

von Lobatón, T. | Ferrante, M. | Rutgeerts, P. | +3

1
2
3
4
5
6
7
Nächster »
[7]